Accolate (zafirlukast) MIGHT lead to liver dysfunction
August 1997
Zeneca is now cautioning that their new asthma drug Accolate (zafirlukast) MIGHT lead to liver dysfunction.
The other leukotriene inhibitor, Zyflo (zileuton) has strong warnings about liver toxicity. Patients starting Zyflo should get at least seven liver function tests in the first year.
With Accolate you only need to suggest liver tests if patients develop symptoms...nausea, jaundice, or abdominal pain.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote